IDEAYA Biosciences, Inc.
7000 Shoreline Court, Suite 350
South San Francisco, California 94080
May 20, 2019
VIA EDGAR ANDE-MAIL
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-6010
Attention: Liz Walsh, Staff Attorney
Chris Edwards, Staff Attorney
Jorge Bonilla, Staff Accountant
Mark Rakip, Staff Accountant
| Re: | IDEAYA Biosciences, Inc. Registration Statement on FormS-1 (RegistrationNo. 333-231081) |
Ladies and Gentlemen:
In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on FormS-1 (FileNo. 333-231081) (the “Registration Statement”) of IDEAYA Biosciences, Inc. (the “Company”). We respectfully request that the Registration Statement become effective as of 4:00 p.m., Washington, D.C. time, on May 22, 2019, or as soon as practicable thereafter, or at such other time thereafter as our legal counsel, Latham & Watkins LLP, may request by telephone to the staff of the U.S. Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Mark Roeder at (650)463-3043 or Adam H. Whitaker at (650)470-4865.
Under separate cover, you will receive today a letter from the managing underwriters of the proposed offering joining in the Company’s request for acceleration of the effectiveness of the Registration Statement.
Thank you for your assistance in this matter.
| Very truly yours, | ||
| IDEAYA BIOSCIENCES, INC. | ||
| By: | /s/ Yujiro Hata | |
Yujiro Hata President and Chief Executive Officer | ||
| CC: | Paul Stone, IDEAYA Biosciences, Inc. |
Mark Roeder, Latham & Watkins LLP |
Benjamin Potter, Latham & Watkins LLP |
Adam H. Whitaker, Latham & Watkins LLP |
Alan F. Denenberg, Davis Polk & Wardwell LLP |
